Baclofen and alcohol use disorders: From miracle to mirage

Affiliations

¹ University Hospital, 80000 Amiens, France. Electronic address: braillon.alain@gmail.com.
² METRICS (Meta-research Innovation Center at Stanford), 1070 Arastradero Road, Palo Alto, CA 94304, USA.

Comment

Alain Braillon et al. Eur Neuropsychopharmacol. 2017 Jul.

. 2017 Jul;27(7):691-692.

doi: 10.1016/j.euroneuro.2017.05.003. Epub 2017 May 26.

¹ University Hospital, 80000 Amiens, France. Electronic address: braillon.alain@gmail.com.
² METRICS (Meta-research Innovation Center at Stanford), 1070 Arastradero Road, Palo Alto, CA 94304, USA.

No abstract available

Comment in

Response to "Baclofen and alcohol use disorders: From miracle to mirage".
Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW. Beraha EM, et al. Eur Neuropsychopharmacol. 2017 Jul;27(7):693-694. doi: 10.1016/j.euroneuro.2017.05.002. Epub 2017 May 30. Eur Neuropsychopharmacol. 2017. PMID: 28576349 No abstract available.

Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW. Beraha EM, et al. Eur Neuropsychopharmacol. 2016 Dec;26(12):1950-1959. doi: 10.1016/j.euroneuro.2016.10.006. Epub 2016 Nov 11. Eur Neuropsychopharmacol. 2016. PMID: 27842939 Clinical Trial.